Liquidia Corporation, (LQDA) is a biopharmaceutical company. It develops, manufactures & commercializes various products for unmet patient needs in the United States. It comes under Healthcare sector in Biotechnology Industry & trades as “LQDA” ticker at Nasdaq.
LQDA is showing higher high since August-2021 low & expect short term upside to extend the sequence started from 7.01.2025 low. It favors rally to extend into $28.98 – $39.60 area as 3 swings bounce from August-2021 low before correcting next.
Since inception in weekly, it made all-time high of $38.46 of October-2018 & all-time low of $2.25 low of August-2021. It needs to break out above $38.46 high to confirm the bullish sequence. From 2021 low, it placed (I) impulse at $19.41 high of May-2025 & (II) at $11.85 low of June-2025. Within (I), it placed I at $7.78 high, II as flat at $4.06 low, III at $16.99 high, IV at $8.26 low & V at $19.41 high. While (II) was 3 swing pullbacks that ended in extreme area. It ended a of (II) at $13.94 low, b at $18.60 high & c at $11.85 low as slightly lower below 0.382 Fibonacci retracement of (I). Above $11.85 low, it favors rally in I of (III) approaching towards $28.98 as minimum extension.
LQDA – Elliott Wave Latest Weekly View:
It placed ((1)) of I at $20.33 high, ((2)) at $16.82 low, ((3)) at $28.00 high & favors pullback in ((4)) correction. It expects ((4)) to end into $25.36 – $23.74 area before final push in ((5)) to finish I. Short term, it expects ((5)) to come with momentum divergence to finish I. But if it managed to erase that, then it can see more upside as the part of ((3)). Since August-2021 low, it shows 3 swings bounce, which either can be impulse or zigzag correction before turn bearish against ATH. So, as long as it holds above 6.30.2025 low, it remains bullish & need to confirm the impulse sequence for further upside. We like to buy the next pullback of II in 3, 7 or 11 swings against 6.30.2025 low.